Shares of Integer Holdings Corporation (NYSE:ITGR – Get Free Report) have been assigned a consensus recommendation of “Hold” from the eleven brokerages that are covering the stock, MarketBeat Ratings reports. One research analyst has rated the stock with a sell recommendation, six have issued a hold recommendation and four have issued a buy recommendation on the company. The average twelve-month target price among analysts that have issued a report on the stock in the last year is $98.2857.
ITGR has been the topic of a number of analyst reports. Raymond James Financial reissued an “outperform” rating and set a $101.00 price target on shares of Integer in a research note on Monday, February 23rd. Wall Street Zen lowered Integer from a “buy” rating to a “hold” rating in a research note on Sunday, January 25th. Weiss Ratings raised Integer from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Tuesday, February 24th. Piper Sandler reissued an “overweight” rating and set a $97.00 price target (up from $87.00) on shares of Integer in a research note on Friday, May 1st. Finally, Zacks Research lowered Integer from a “hold” rating to a “strong sell” rating in a research note on Monday, May 11th.
Get Our Latest Analysis on ITGR
Insider Buying and Selling at Integer
Institutional Inflows and Outflows
Several large investors have recently made changes to their positions in ITGR. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its position in shares of Integer by 4.0% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 21,515 shares of the medical equipment provider’s stock worth $2,539,000 after buying an additional 837 shares during the period. Millennium Management LLC raised its position in shares of Integer by 2,408.8% in the 1st quarter. Millennium Management LLC now owns 123,132 shares of the medical equipment provider’s stock worth $14,531,000 after buying an additional 118,224 shares during the period. Jones Financial Companies Lllp raised its position in shares of Integer by 79,888.9% in the 1st quarter. Jones Financial Companies Lllp now owns 7,199 shares of the medical equipment provider’s stock worth $850,000 after buying an additional 7,190 shares during the period. United Services Automobile Association purchased a new position in shares of Integer in the 1st quarter worth $258,000. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its position in shares of Integer by 4.7% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 109,316 shares of the medical equipment provider’s stock worth $12,900,000 after buying an additional 4,873 shares during the period. 99.29% of the stock is owned by hedge funds and other institutional investors.
Integer Stock Performance
ITGR opened at $88.15 on Monday. The stock has a market cap of $2.99 billion, a P/E ratio of 21.98, a P/E/G ratio of 2.08 and a beta of 0.67. The company has a debt-to-equity ratio of 0.77, a current ratio of 3.75 and a quick ratio of 2.38. The stock’s 50 day simple moving average is $86.23 and its 200 day simple moving average is $80.99. Integer has a 1-year low of $62.00 and a 1-year high of $123.78.
Integer (NYSE:ITGR – Get Free Report) last announced its earnings results on Thursday, April 30th. The medical equipment provider reported $1.20 EPS for the quarter, missing analysts’ consensus estimates of $1.21 by ($0.01). The company had revenue of $439.58 million for the quarter, compared to analyst estimates of $426.48 million. Integer had a net margin of 7.64% and a return on equity of 12.83%. Integer’s quarterly revenue was up .5% compared to the same quarter last year. During the same quarter last year, the company posted $1.31 EPS. Integer has set its FY 2026 guidance at 5.830-6.400 EPS. As a group, equities analysts anticipate that Integer will post 6.11 EPS for the current fiscal year.
Integer Company Profile
Integer Holdings Corporation (NYSE: ITGR) is a global provider of outsourced medical device design, development and manufacturing solutions. The company partners with leading medical technology firms to deliver complex components, subsystems and finished devices across a range of therapeutic areas. Its services encompass concept and product design, precision machining, microelectronic assembly, terminal sterilization and regulatory support, enabling customers to accelerate time to market and optimize product performance.
Integer’s product portfolio is organized into two core segments: Advanced Delivery and MedTech.
Featured Articles
- Five stocks we like better than Integer
- Robinhood, SoFi, and Webull Are Telling Very Different Stories
- As Broadcom Eclipses $2 Trillion, Private Credit Giants Wants In
- Target the Red-Hot Spin-Off and Merger Space With These ETFs
- Samsung Joins the $1 Trillion Club as AI Memory Demand Explodes
Receive News & Ratings for Integer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integer and related companies with MarketBeat.com's FREE daily email newsletter.
